SCHEMBL185236

SCHEMBL185236

N#Cc1ccccc1Nc1ccc(CN)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
KDM4E B2RXH2 4/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GAA P10253 4/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.44
AURKA O14965 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CXCR2 P25025 1/20 0.41
LRRK2 Q5S007 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL185638 0.87 TAS2R14 (0.46) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL20552825 0.83 HPGD (0.60) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL4188631 0.80 AURKA (0.59) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL16481161 0.79 KDM4E (0.49) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL27853555 0.78 LRRK2 (0.46) HPGDKDM4EGAALMNASMN1; SMN2
SCHEMBL185390 0.78 LRRK2 (0.47) HPGDKDM4EGAALMNASMN1; SMN2
SCHEMBL24681745 0.77 KDR (0.51) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL16481316 0.77 LMNA (0.62) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL28216056 0.77 GAA (0.55) HPGDKDM4ETSHRHSD17B10GAA
SCHEMBL4193666 0.77 KDM4E (0.62) HPGDKDM4ETSHRHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102414177-A Compounds as bradykinin b1 antagonists BOEHRINGER INGELHEIM INT 2012-04-11 CN disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed